محصولات

# Product Name Therapeutic Area CAS No. Standard Status
1 Sitagliptin phosphate monohydrate Diabetes 654671-77-9 USP Available
2 Empagliflozin Diabetes 864070-44-0 In-house Available
3 Linagliptin Diabetes 668270-12-0 In-house Available
4 Gliclazide Diabetes 21187-98-4 BP Available
5 Telmisartan Cardiology 144701-48-4 USP Available
6 Rosuvastatin calcium Cardiology 147098-20-2 EP / BP Available
7 Apixaban Cardiology 503612-47-3 In-house Available
8 Valsartan Cardiology 137862-53-4 USP Available
9 Amlodipine besylate Cardiology 111470-99-6 USP Available
10 Apremilast Immunology 608141-41-9 In-house Available
11 Palbociclib Oncology 571190-30-2 In-house Available
12 Levetiracetam Neurology 102767-28-2 BP Available
13 Nintedanib esylate Oncology 656247-18-6 In-house Under Development
14 Ibrutinib Oncology 936563-96-1 In-house Under Development
15 Abemaciclib Oncology 1231929-97-7 In-house Under Development
16 Venetoclax Oncology 1257044-40-8 In-house Under Development
17 Dapagliflozin propanediol monohydrate Diabetes 960404-48-2 In-house Under Development
18 Semaglutide Diabetes 910463-68-2 In-house Under Development
19 Ozanimod hydrochloride Neurology 1618636-37-5 In-house Under Development
20 Rimegepant sulfate Neurology 1374024-48-2 In-house Under Development
21 Montelukast sodium Respiratory 151767-02-1 BP Under Development
22 Desloratadine Respiratory 100643-71-8 USP Under Development
23 Mavacamten Cardiology 1642288-47-8 In-house Under Development
24 Finerenone Cardiorenal 1050477-31-0 In-house Under Development
25 Vonoprazan fumarate Gastroenterology 881681-01-2 In-house Under Development
26 Upadacitinib hemihydrate Immunology 2050057-56-0 In-house Under Development
27 Levofloxacin hemihydrate Infectious Diseases 138199-71-0 USP Under Development
بازگشت به بالا